211 related articles for article (PubMed ID: 3614812)
1. Serum copper and zinc levels in premalignant and malignant lesions of the oral cavity.
Varghese I; Sugathan CK; Balasubramoniyan G; Vijayakumar T
Oncology; 1987; 44(4):224-7. PubMed ID: 3614812
[TBL] [Abstract][Full Text] [Related]
2. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum beta 2-microglobulin in premalignant and malignant lesions of the oral cavity.
Anil S; Beena VT; Nair RG; Vijayakumar T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jun; 79(6):750-2. PubMed ID: 7621034
[TBL] [Abstract][Full Text] [Related]
4. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
Rai B; Kaur J; Jacobs R; Singh J
J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
[TBL] [Abstract][Full Text] [Related]
5. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
Sawhney H; Kumar CA
Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
Rajpura KB; Patel PS; Chawda JG; Shah RM
J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
[TBL] [Abstract][Full Text] [Related]
7. Assessment of serum copper, iron and immune complexes in potentially malignant disorders and oral cancer.
Tiwari R; David CM; Mahesh DR; Sambargi U; Rashmi KJ; Benakanal P
Braz Oral Res; 2016 Oct; 30(1):e101. PubMed ID: 27737355
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of copper, zinc, iron and ceruplasmin in oral leukoplakia and squamous cell carcinoma.
Jayadeep A; Raveendran Pillai K; Kannan S; Nalinakumari KR; Mathew B; Krishnan Nair M; Menon VP
J Exp Clin Cancer Res; 1997 Sep; 16(3):295-300. PubMed ID: 9387904
[TBL] [Abstract][Full Text] [Related]
9. [How to improve the diagnostic and therapeutic levels of oral premalignant lesions].
Zhou ZT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):89-91. PubMed ID: 15842851
[No Abstract] [Full Text] [Related]
10. Determination of role of ceruloplasmin in oral potentially malignant disorders and oral malignancy-A cross-sectional study.
Shah PH; Venkatesh R; More CB
Oral Dis; 2017 Nov; 23(8):1066-1071. PubMed ID: 28513913
[TBL] [Abstract][Full Text] [Related]
11. Estimation of serum copper and zinc levels in oral submucous fibrosis: an atomic absorption spectroscopic study.
Neethi H; Patil S; Rao RS
J Contemp Dent Pract; 2013 Sep; 14(5):801-5. PubMed ID: 24685778
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of premalignant lesions and early cancers of the oral cavity.
Gillenwater AM; Chambers MS
Tex Dent J; 2006 Jun; 123(6):512-20. PubMed ID: 16875018
[No Abstract] [Full Text] [Related]
13. Trace elements (copper, zinc, selenium and molybdenum) as markers in oral sub mucous fibrosis and oral squamous cell carcinoma.
Khanna S; Udas AC; Kumar GK; Suvarna S; Karjodkar FR
J Trace Elem Med Biol; 2013 Oct; 27(4):307-11. PubMed ID: 23664922
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.
Raval GN; Patel DD; Parekh LJ; Patel JB; Shah MH; Patel PS
Oral Dis; 2003 May; 9(3):119-28. PubMed ID: 12945593
[TBL] [Abstract][Full Text] [Related]
15. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions.
Patel PS; Shah MH; Jha FP; Raval GN; Rawal RM; Patel MM; Patel JB; Patel DD
Indian J Cancer; 2004; 41(1):25-31. PubMed ID: 15105576
[TBL] [Abstract][Full Text] [Related]
16. Cytomorphometric analysis of oral submucous fibrosis and leukoplakia using methyl green-pyronin Y, Feulgen staining and exfoliative brush cytology.
Metgud R; Gupta K; Prasad U; Gupta J
Biotech Histochem; 2015 Jan; 90(1):8-13. PubMed ID: 24867495
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of iron and proteins in oral submucous fibrosis (OSMF).
Rajendran R; Vasudevan DM; Vijayakumar T
Ann Dent; 1990; 49(2):23-5, 45. PubMed ID: 2278476
[TBL] [Abstract][Full Text] [Related]
18. A community-based RCT for oral cancer screening with toluidine blue.
Su WW; Yen AM; Chiu SY; Chen TH
J Dent Res; 2010 Sep; 89(9):933-7. PubMed ID: 20525960
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse.
Lohe VK; Degwekar SS; Bhowate RR; Kadu RP; Dangore SB
J Oral Pathol Med; 2010 Feb; 39(2):141-8. PubMed ID: 20002982
[TBL] [Abstract][Full Text] [Related]
20. Update on precancerous lesions.
McIntyre GT; Oliver RJ
Dent Update; 1999 Nov; 26(9):382-6. PubMed ID: 10765779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
